- Report
- March 2023
- 64 Pages
Asia Pacific
From €1320EUR$1,500USD£1,145GBP
- Report
- March 2023
- 64 Pages
Europe
From €1320EUR$1,500USD£1,145GBP
- Report
- March 2023
- 59 Pages
North America
From €1320EUR$1,500USD£1,145GBP
- Report
- February 2024
- 160 Pages
Global
From €4371EUR$4,969USD£3,793GBP
- Report
- May 2023
- 87 Pages
Global
From €3075EUR$3,495USD£2,668GBP
- Drug Pipelines
- January 2022
- 84 Pages
Global
From €8793EUR$9,995USD£7,629GBP
- Report
- March 2023
- 255 Pages
Global
From €1100EUR$1,250USD£954GBP
€2199EUR$2,500USD£1,908GBP
From €660EUR$750USD£572GBP
€1320EUR$1,500USD£1,145GBP
- Report
- March 2023
- 80 Pages
South Korea
From €660EUR$750USD£572GBP
€1320EUR$1,500USD£1,145GBP
- Report
- March 2023
- 80 Pages
Saudi Arabia
From €660EUR$750USD£572GBP
€1320EUR$1,500USD£1,145GBP
- Report
- March 2023
- 80 Pages
Russia
From €660EUR$750USD£572GBP
€1320EUR$1,500USD£1,145GBP
- Report
- March 2023
- 80 Pages
Germany
From €660EUR$750USD£572GBP
€1320EUR$1,500USD£1,145GBP
- Report
- March 2023
- 80 Pages
France
From €660EUR$750USD£572GBP
€1320EUR$1,500USD£1,145GBP
- Report
- March 2023
- 80 Pages
China
From €660EUR$750USD£572GBP
€1320EUR$1,500USD£1,145GBP
- Report
- April 2025
- 107 Pages
China
From €1583EUR$1,800USD£1,374GBP
- Report
- April 2025
- 54 Pages
China
From €1583EUR$1,800USD£1,374GBP
- Report
- August 2024
- 215 Pages
Global
From €4394EUR$4,995USD£3,813GBP
- Report
- October 2022
- 27 Pages
Global
€10776EUR$12,250USD£9,351GBP
- Report
- November 2022
- 76 Pages
Global
From €1759EUR$2,000USD£1,527GBP
- Report
- November 2022
- 63 Pages
Global
From €1759EUR$2,000USD£1,527GBP

Proton Pump Inhibitors (PPIs) are a class of drugs used to treat Gastrointestinal (GI) disorders. They work by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux, heartburn, and other GI conditions. PPIs are available in both prescription and over-the-counter forms, and are often used in combination with other medications to treat more severe GI conditions. Common side effects of PPIs include headache, nausea, and diarrhea.
PPIs are among the most widely prescribed drugs in the world, and are used to treat a variety of GI conditions. They are often used as a first-line treatment for acid reflux and other GI disorders, and are also used to prevent and treat ulcers.
Some of the major companies in the PPI market include AstraZeneca, Pfizer, Takeda, and GlaxoSmithKline. These companies produce a variety of PPIs, including omeprazole, lansoprazole, and pantoprazole. Show Less Read more